| MolName | 4-[(E)-[4-[(3-chlorophenyl)methyl]-3-oxo-1,4-benzothiazin-2-ylidene]methyl]-N-(2-phenylethyl)benzamide |
| MolecularFormula | C31H25N2O2ClS |
| Smiles | O=C(c1ccc(/C=C2/Sc(cccc3)c3N(Cc3cccc(Cl)c3)C2=O)cc1)NCCc1ccccc1 |
| InChI | InChI=1S/C31H25ClN2O2S/c32-26-10-6-9-24(19-26)21-34-27-11-4-5-12-28(27)37-29(31(34)36)20-23-13-15-25(16-14-23)30(35)33-18-17-22-7-2-1-3-8-22/h1-16,19-20H,17-18,21H2,(H,33,35) |
| InChIK | STCRLPQVMISONG-UHFFFAOYSA-N |
| TotalMolweight | 525.071 |
| Molweight | 525.071 |
| MonoisotopicMass | 524.132525 |
| CLogP | 5.9264 |
| CLogS | -7.889 |
| H Acceptors | 4 |
| H Donors | 1 |
| TotalSurfaceArea | 395.2 |
| Relative PSA | 0.14823 |
| PolarSurfaceArea | 74.71 |
| Druglikeness | 5.0969 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.56757 |
| Fragments | 1 |
| Non HAtoms | 37 |
| NonCHAtoms | 6 |
| Electronegative Atoms | 6 |
| Rotatable Bond | 7 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 24 |
| Sp3Atoms | 4 |
| Symmetricatoms | 4 |
| Amides | 2 |
| StereoCon |
Click to Load Molecule:
1 - 4-[(E)-[4-[(3-chlorophenyl)methyl]-3-oxo-1,4-benzothiazin-2-ylidene]methyl]-N-(2-phenylethyl)benzamide | 2 - 4-[(E)-[4-[(3-chlorophenyl)methyl]-3-oxo-1,4-benzothiazin-2-ylidene]methyl]-N-(2-phenylethyl)benzamide